Adhesions from prior abdominal surgeries are the most common cause of SBO. Untreated SBO can lead to serious complications like bowel perforation or tissue death (strangulation). Symptoms of SBO ...

The FDA gave premarket approval to the first medical device for the treatment of women with symptomatic moderate-to-severe intrauterine adhesions, known as Asherman syndrome, maker Womed announced on ...

Up to 90% of abdominal surgeries result in adhesions -- abnormal scarring that ties together organs and tissues. A gel has now been shown to prevented adhesions in mice and pigs. Surgical adhesions -- ...

BEDFORD, Mass.--(BUSINESS WIRE)--Rejoni, Inc., a privately held clinical-stage company, today announced the completion of enrollment of 150 patients in the Juveena Hydrogel pivotal clinical study.

Credit: Womad. The Womed Leaf consists of a proprietary polymer that is inserted into the uterine cavity immediately after completion of a hysteroscopic adhesiolysis procedure. The device is indicated ...

For permission requests, please contact NEJM Reprints at [email protected] ...